Hyperoxaluria, Primary, Type II

Alternative Names

  • HP2
  • Oxalosis II
  • Glycerin Aciduria
  • Glyoxylate Reductase/Hydroxypyruvate Reductase Deficiency
  • D-Glycerate Dehydrogenase Deficiency
Back to search Result
WHO-ICD-10 version:2010

Endocrine, nutritional and metabolic diseases

Metabolic disorders

OMIM Number

260000

Description

Primary hyperoxaluria type I is an autosomal recessive disorder characterized by an accumulation of calcium oxalate in various bodily tissues, especially the kidney, resulting in renal failure. Affected individuals have decreased or absent AGXT activity and a failure to transaminate glyoxylate, which causes the accumulated glyoxylate to be oxidized to oxalate. This overproduction of oxalate results in the accumulation of nonsoluble calcium oxalate in various body tissues, with pathologic sequelae. Type III primary hyperoxaluria is caused by mutation in the mitochondrial dihydrodipicolinate synthase-like gene (DHDPSL) on chromosome 10q24. [From OMIM]

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
260000.1LebanonUnknownYes HyperoxaluriaNM_012203.2:c.344C>AHomozygousAutosomal, RecessiveJalkh et al. 2019
© CAGS 2024. All rights reserved.